Clinical trial
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast…
NCT00429507 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00429507 |
|---|---|
| Title | Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases |
| Official title | Phase 2 Study of 153 Sm-EDTMP Followed by Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Cytogen Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Bone Metastases |
| Intervention type | Behavioral, Drug, Procedure |
| Interventions | 153 Sm-EDTMP, Questionnaire, Stem Cell Transplant |
| Enrollment | 12 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | Jan 31, 2007 |
| Last update posted | Nov 24, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: